Who is sponsoring NCT03602924?

NCT03602924 is sponsored by Hospital Universitari Vall d'Hebron Research Institute.

What condition does NCT03602924 study?

NCT03602924 studies Parkinson Disease.

What is the status of NCT03602924?

NCT03602924 is currently UNKNOWN.

Last reviewed 2018-07-27 · How we verify

Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion

NCT03602924 UNKNOWN

Levodopa-carbidopa intestinal gel (LCIG) infusion has demonstrated to improve motor fluctuations. The aim of this study is to assess the long-term safety and effectiveness of LCIG infusion in advanced Parkinson's disease (PD) patients with motor fluctuations and its effect in non-motor symptoms.

Details

Lead sponsor	Hospital Universitari Vall d'Hebron Research Institute
Status	UNKNOWN
Enrolment	40
Start date	Mon Dec 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Dec 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Parkinson Disease

Countries

Spain